Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $10.9 million.

  • Sanara MedTech's Accumulated Expenses rose 3172.5% to $10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 3172.5%. This contributed to the annual value of $10.1 million for FY2024, which is 3136.58% up from last year.
  • As of Q3 2025, Sanara MedTech's Accumulated Expenses stood at $10.9 million, which was up 3172.5% from $10.2 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Accumulated Expenses registered a high of $10.9 million during Q3 2025, and its lowest value of $2.2 million during Q1 2021.
  • For the 5-year period, Sanara MedTech's Accumulated Expenses averaged around $6.3 million, with its median value being $6.3 million (2022).
  • Per our database at Business Quant, Sanara MedTech's Accumulated Expenses skyrocketed by 11977.83% in 2022 and then tumbled by 388.55% in 2023.
  • Quarter analysis of 5 years shows Sanara MedTech's Accumulated Expenses stood at $4.5 million in 2021, then soared by 71.69% to $7.8 million in 2022, then dropped by 1.05% to $7.7 million in 2023, then soared by 31.37% to $10.1 million in 2024, then rose by 7.85% to $10.9 million in 2025.
  • Its last three reported values are $10.9 million in Q3 2025, $10.2 million for Q2 2025, and $8.2 million during Q1 2025.